Home
Board Review Course
Study Summaries
Publication Updates
Videos
Support and Policies
Leadership
Work Life Balance

Subscribe

Keynote B21 - Pembrolizumab in High-Risk Endometrial Cancer (Video Explainer)

Last updated on Oct 27, 2024

This post is for paying subscribers only

Subscribe now

Already have an account? Sign in

Previous Keynote B-21: Pembrolizumab vs. Placebo in High-risk Endometrial Cancer

Next The Living Room

GYOEDU Plus © 2024

Sign up

Powered by Ghost